Wednesday, November 5, 2025
HomeNews

News

Active Motif and EpiCypher Execute Cross-Licensing Agreement

CUT&Tag is a targeted transposition technique that allows high-resolution genomic mapping of histone modifications and chromatin-associated proteins through the precise insertion of DNA sequences...

Innovent and Laekna Jointly Announce First Patient Dosed with Three-drug Combination

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and other...

Sen-Jam Pharmaceutical, Turns To Crowdfunding To Secure Financing

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel combination therapy, started and will...

SHINE Technologies Submits Drug Master File with the U.S. Food and Drug Administration

SHINE Technologies, LLC, a next-generation nuclear technology company, announced the company has submitted a Drug Master File (DMF) with the U.S. Food and Drug...

The News This Week: Read Magazine’s Weekly News Roundup Featuring, NATA, SkyDrive, OpenText, And Alphanect

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast paced world, breaking down information helps readers grasp...
0FansLike
0FollowersFollow
spot_img

Hot Topics